Cosmo to Host Investor Day on April 9, 2025
Rhea-AI Summary
Cosmo Pharmaceuticals has announced it will host an Investor Day on Wednesday, April 9, 2025, at the Park Hyatt Hotel in Zurich, Switzerland. The event will commence at 11:00am CET, featuring presentations followed by lunch.
The program will include detailed presentations from the Management team covering the company's R&D pipeline, long-term strategic initiatives, and growth opportunities. CEO Giovanni Di Napoli and the executive team will conduct a Q&A session with investors, analysts, and media representatives.
Registration details for in-person attendance and live webcast information will be available in the Events & Presentations section of Cosmo's website. A replay of the webcast will be provided after the event.
Positive
- None.
Negative
- None.
News Market Reaction – CMOPF
On the day this news was published, CMOPF gained 4.83%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Dublin, Ireland--(Newsfile Corp. - February 12, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce that it will host an Investor Day on Wednesday, April 9, 2025.
The live event will be held at the Hotel “Park Hyatt” at Beethovenstrasse 21 in 8002 Zurich, Switzerland. The presentation will begin at 11:00am CET and will be followed by lunch.
Cosmo’s Investor Day event will include presentations from the Management team on Cosmo’s R&D pipeline, long-term strategic initiatives and growth opportunities. CEO Giovanni Di Napoli and the executive team are looking forward to the subsequent Q&A session with investors, analysts and media representatives.
The link with registration details (for those attending in person) along with the live webcast details (for those joining online) will be made available under the Events & Presentations section of Cosmo’s website. A replay of the webcast will be available after the event.
About Cosmo
Cosmo Pharmaceuticals N.V. is committed to revolutionizing healthcare and transforming people’s lives by researching and developing innovative products that tackle unfulfilled healthcare demands. As a pharmaceutical company, Cosmo is active in the areas of Healthtech/AI, dermatology, gastroenterology and contract manufacturing & development. For the commercialization and distribution of its products, Cosmo collaborates with leading partners worldwide, including Medtronic and Sun Pharma. Founded in 1997, Cosmo is headquartered in Dublin (Ireland) and has offices also in San Diego (USA), and Lainate/Rome/Catania (Italy). The Company had approximately 330 employees at the end of 2024, all dedicated to making a significant impact in the field of healthcare. For more information, please visit www.cosmopharma.com.
Upcoming Events
| 2024 Full-Year Results (unaudited) | March 6, 2025 |
| J.P. Morgan European Opportunities Forum, London | March 12, 2025 |
| 2024 Annual Report Publication | March 20, 2025 |
| 26th Kepler Cheuvreux Swiss Seminar, Zurich | March 20, 2025 |
| Life Sciences Conference, Amsterdam | April 2-3, 2025 |
| Investor Day 2025 | April 9, 2025 |
| 2025 Half-Year Results and Report | July 23, 2025 |
For information requests about Cosmo’s Investor Day 2025, please contact:
Hazel Winchester, Head of Investor Relations
Cosmo Pharmaceuticals N.V.
Tel: +353 1 817 03 70
hwinchester@cosmopharma.com
Attachments
250212_Cosmo_Announcement_Investor Day 2025_english_final
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240533
FAQ
When and where is Cosmo Pharmaceuticals' 2025 Investor Day?
What topics will be covered at Cosmo's 2025 Investor Day?
How can investors participate in Cosmo's 2025 Investor Day?
Will there be a Q&A session at Cosmo's 2025 Investor Day?
Will Cosmo's 2025 Investor Day presentation be available after the event?
